Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease
- PMID: 15634723
- DOI: 10.1210/jc.2004-1087
Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease
Abstract
Background: Elevated plasma asymmetrical dimethylarginine (ADMA) is suggested to contribute to hyperhomocyst(e)ine-related vascular dysfunction in patients with peripheral artery disease (PAD). The present trial investigated whether homocyst(e)ine (Hcy)-lowering therapy with vitamin-B (vit-B) and folic acid affects plasma concentrations of ADMA in patients with PAD and hyperhomocyst(e)inemia.
Subjects and methods: Forty-nine subjects (15 women, 34 men) with PAD and fasting plasma total Hcy concentrations greater than 15 micromol/liter were randomized to receive either oral vit-B and folic acid therapy (n = 27) or placebo (n = 22) for 6 wk. Fasting venous blood samples were monitored for plasma total Hcy, vit-B12 and folate, ADMA, symmetric dimethylarginine, L-arginine, and high-sensitivity C-reactive protein.
Results: After 6 wk, plasma Hcy concentrations were decreased, and concentrations of vit-B12 and folate were elevated in patients with vitamin supplementation (all P < 0.05 vs. baseline) and unchanged in the placebo group. Dimethylarginine plasma concentrations were not affected by treatment. High-sensitivity C-reactive protein correlated with ADMA plasma concentrations (r = 0.29; P < 0.01).
Conclusion: The lack of vit-B and folic acid therapy on plasma concentrations of ADMA renders a role of extracellular methylarginines unlikely to be involved in the pathophysiology of hyperhomocyst(e)inemia and its complications.
Similar articles
-
Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.Curr Drug Metab. 2005 Feb;6(1):3-14. doi: 10.2174/1389200052997393. Curr Drug Metab. 2005. PMID: 15720202 Review.
-
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.Cardiovasc Res. 2003 Jan;57(1):244-52. doi: 10.1016/s0008-6363(02)00617-x. Cardiovasc Res. 2003. PMID: 12504835 Clinical Trial.
-
[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].Z Kardiol. 2001 Jan;90(1):1-11. doi: 10.1007/s003920170206. Z Kardiol. 2001. PMID: 11220081 Review. German.
-
Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.Clin Sci (Lond). 2001 Feb;100(2):161-7. Clin Sci (Lond). 2001. PMID: 11171285
-
Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1557-64. doi: 10.1161/01.atv.20.6.1557. Arterioscler Thromb Vasc Biol. 2000. PMID: 10845872
Cited by
-
Effect of Combined Treatment With Folic Acid, Vitamin B6, and Vitamin B12 on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women.J Am Heart Assoc. 2018 May 18;7(11):e008517. doi: 10.1161/JAHA.117.008517. J Am Heart Assoc. 2018. PMID: 29776960 Free PMC article. Clinical Trial.
-
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis.Mediators Inflamm. 2018 Jan 18;2018:3897295. doi: 10.1155/2018/3897295. eCollection 2018. Mediators Inflamm. 2018. PMID: 29576746 Free PMC article. Review.
-
Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.Eur J Nutr. 2010 Dec;49(8):483-92. doi: 10.1007/s00394-010-0107-x. Epub 2010 Apr 18. Eur J Nutr. 2010. PMID: 20401662 Clinical Trial.
-
Medium-term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline.Eur J Nutr. 2006 Oct;45(7):383-90. doi: 10.1007/s00394-006-0611-1. Epub 2006 Sep 1. Eur J Nutr. 2006. PMID: 17061018
-
Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.J Inherit Metab Dis. 2006 Feb;29(1):30-7. doi: 10.1007/s10545-006-0208-0. J Inherit Metab Dis. 2006. PMID: 16601865
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials